Christos Coutifaris
Director/Miembro de la Junta en American Society for Reproductive Medicine .
Perfil
Christos Coutifaris is a Member of the Board of Directors at the American Society for Reproductive Medicine.
He was previously a Member of the Clinical Advisory Board at Nora Therapeutics, Inc.
Cargos activos de Christos Coutifaris
Empresas | Cargo | Inicio |
---|---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Christos Coutifaris.
Empresas | Cargo | Fin |
---|---|---|
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Commercial Services |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Christos Coutifaris